Torsten Hoffmann

Torsten Hoffmann

Corporate Officer/Principal en
American Chemical Society
.
59 años
Health Technology
Commercial Services
Consumer Services

Perfil

Torsten Hoffmann is a member of the American Chemical Society and the Swiss Chemical Society.
He was the Managing Director & Chief Scientific Officer at Proteros biostructures GmbH.
He was also the Head-Global Roche Postdoc at Roche Holding AG from 1999 to 2015.
In 2017 to 2018, he was the Chief Operating Officer at Silence Therapeutics Plc.
He was an Associate at The Scripps Research Institute and the Chief Scientific Officer at Oryzon Genomics SA. He was also the Chief Scientific Officer & Executive VP at Zealand Pharma A from 2013 to 2015.
Dr. Hoffmann holds a doctorate degree from the Swiss Federal Institute of Technology.
Currently, he holds positions as a member of the American Chemical Society and the Swiss Chemical Society.

Cargos activos de Torsten Hoffmann

EmpresasCargoInicio
Corporate Officer/Principal -
Corporate Officer/Principal -

Antiguos cargos conocidos de Torsten Hoffmann.

EmpresasCargoFin
SILENCE THERAPEUTICS PLC Director de Operaciones 21/06/2018
ZEALAND PHARMA A/S Director Técnico/Científico/I+D 01/01/2015
ROCHE HOLDING AG Corporate Officer/Principal 01/01/2015
ORYZON GENOMICS S.A. Director Técnico/Científico/I+D -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Torsten Hoffmann.

Formación de Torsten Hoffmann.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

68

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Health Technology

Commercial Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Services

  1. Bolsa de valores
  2. Insiders
  3. Torsten Hoffmann